The community of colleagues supporting each other through redundancy

Last November, Pfizer announced plans to discontinue its Pharmaceutical Sciences Small Molecule capabilities at its Discovery Park location in Sandwich, UK, to consolidate the facilities at two primary sites, one in the US and one in India.

This decision impacted approximately 500 roles, more than half of the 940 people currently employed at the facility.

Research fellow Ivan Marziano was one of those to be made redundant, along with his entire team.